FATE Overview
Upcoming Projects (FATE)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (FATE)
-
Discussing the trends in the NK cell landscape for the future of CART therapies, specifically FATE therapeutics and their iPSC-Derived cell products
Tickers: FATE, SNY
Executed On: Dec 16, 2022 at 09:00 AM EST -
Discussing the IPSC and NK cell infusion landscape in the oncology space with a focus on technologies in development by Editas and Fate Therapeutics
Tickers: FATE, EDIT
Executed On: Jan 19, 2022 at 02:00 PM EST
Upcoming & Overdue Catalysts (FATE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (FATE)
-
Fate Therapeutics' (FATE) FT596 Off-the-Shelf, iPSC-derived CAR NK Cell Cancer Immunotherapy Preclinical Data Presented at ASH
Ticker: FATE
Occurred on: Dec 08, 2019
Strategic Initiatives (FATE)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
